HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alzheimer's disease: Newer biomarkers.

Abstract
Fifty million people are affected with dementia worldwide with Alzheimer's disease (AD) accounting for 70%-80% of these cases. In India alone, 4.1 million people suffered from dementia in 2015. To date, there are no definitive treatment options for AD and the overall treatment gap in India stands at 90%. Attempts have been made to define AD biologically. This has been made possible due to advances in the identification of biomarkers that indicate the neuropathological changes responsible for AD. Identification of these biomarkers has implications for disease staging, prognostication, and identifying drug targets. Here, we summarize the advances in the field of biomarkers in AD.
AuthorsAnkit Dangi, Kaushik Chatterjee, Manjur Shah Banwa, Vinay Singh Chauhan, Prateek Yadav
JournalIndustrial psychiatry journal (Ind Psychiatry J) Vol. 30 Issue Suppl 1 Pg. S315-S319 (Oct 2021) ISSN: 0972-6748 [Print] India
PMID34908720 (Publication Type: Journal Article)
CopyrightCopyright: © 2021 Industrial Psychiatry Journal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: